Skip to main content Accessibility help
×
Home
  • Print publication year: 2010
  • Online publication date: December 2010

Section 11 - Adjuvant Analgesics and Antiemetics

References

1. RaederJ, DahlV. Clinical application of glucocorticoids, anti-neuropathics and other analgesic adjuvants for acute pain management. In SinatraR et al., eds. Acute Pain Management. Cambridge University Press, 2009, pp. 377–390.
2. SalernoA, HermannR. Efficacy and safety of steroid use for post-operative pain relief. Update and review of the medical literature. J Bone Joint Surg Am 2006;88:1361–1372.
3. AbdiS, DattaS, TrescotAM, et al. Epidural steroids in the management of chronic spinal pain: a systematic review. Pain Physician 2007;10:185–212.
4. ArrollB, Goodyear-SmithF. Corticosteroid injections for painful shoulder: a meta-analysis. Br J Gen Pract 2005;55:224–228.
5. BellamyN, CampbellJ, RobinsonV, et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005;CD005328.
6. GrusonKI, RuchelsmanDE, ZuckermanJD. Subacromial corticosteroid injections. J Shoulder Elbow Surg 2008;17:118S–130S.
7. StaalJB, de BieRA, de VetHC, et al. Injection therapy for subacute and chronic low back pain: an updated Cochrane review. Spine (Phila Pa 1976) 2009;34:49–59.
8. StaffordMA, PengP, HillDA. Sciatica: a review of history, epidemiology, pathogenesis, and the role of epidural steroid injection in management. Br J Anaesth 2007;99:461–73.

References

1.DynaMed®, EBSCO Publishing. Dexamethasone, 2009.
2.DynaMed®, EBSCO Publishing. Prednisone, 2009.
3.Micromedex®Healthcare Series, DrugDex® Evaluations, Martindale – The Complete Drug Reference, and Posindex®, Tompson Healthcare. Dexamethasone, 2009.
4.Micromedex®Healthcare Series, DrugDex® Evaluations, Martindale – The Complete Drug Reference, and Posindex®, Tompson Healthcare. Prednisone, 2009.
5. KnotkovaH, PappagalloM. Adjuvant analgesics. Anesthesiol Clin North Am 2007:27:775–786.
6. LussierD, HuskeyA, PortenoyR. Adjuvant analgesics in cancer pain management. Oncologist 2004;9:571–591.

References

1. SimonsFE. Advances in H1-antihistamines. N Engl J Med 2004;351(21):2203–2217.
2. YilmazE, ErtanB, DenizT, et al. Histamine 1 receptor antagonist in symptomatic treatment of renal colic accompanied by nausea: two birds with one stone?Urology 2009;73(1):32–36.
3.Micromedex® Healthcare Series, DrugDex® Evaluations.
4. BertholdCW, DionneRA. Clinical evaluation of H1-receptor and H2-receptor antagonists for acute postoperative pain. J Clin Pharmacol 1993;33:944–948.
5. SimonsFE. H1-antihistamines: more relevant than ever in the treatment of allergic disorders. J Allergy Clin Immunol 2003;112(4):S42–S52.

References

1. GanTJ, MeyerTA, ApfelCC, et al. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting (special article). Anesth Analg 2007;105:1615–1628.
2. GolembiewskiJ, CherninE, ChopraT. Prevention and treatment of postoperative nausea and vomiting. Am J Health Syst Pharm 2005;62:1247–1260.
3. DominoKB, AndersonEA, PolissarNK, et al. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999;88:1370–1379.
4. RungGW, ClaybonL, HordA, et al. The intravenous ondansetron for postsurgical opioid-induced nausea and vomiting. Anesth Analg 1997;84:832–838.
5. ApfelCC, KorttilaK, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. NEJM 2004;350(24):2441–2451.

References

1. RoilaF, FatigoniS. New antiemetic drugs. Ann Oncol 2006;(supplement 2):96–100.
2. GirishC, ManikandanS. Indian J Cancer 2007;44: 5–30.
3. SoodM, et al. Aprepitant in PONV. Clin Pharmacol 2007;23(4):395–398.
4. GanT, et al. A randomized, double-blind comparison of the NK1-antagonist, aprepitant, versus ondansetron for the prevention of postoperative nausea and vomiting. Anesth Analg 2007;104:1082–1089.
5.Aprepitant Oral: AHFS detailed monograph. Aprepitant/Fosaprepitant Dimeglumine http://cme.medscape.com/druginfo/monograph. Class Antiemetics, miscellaneous (56:22.92).
6.Product information: Aprepitant capsules (Emend–Merk) 2006.

References

1. KotelkoDM, et al. Transdermal scopolaine decreases nausea and vomiting following cesarean section in patients receiving epidural morphine. Anesthesiology 1989;71:675–678.
2. GanTJ, et al. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007;105(6):1615–1628.
3. ClissoldSP, et al. Transdermal hyoscine (scopolamine): a prelimary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 1985;29:189–207.
4. CroninCM, et al. Transdermal scopolamine in motion sickness. Pharmacotherapy 1982;2:29–31.
5.Transderm Scopolamine (package insert). Deerfield, IL: Baxter Healthcare Corporation; 2003.

References

1. PittlerMH, ErnstE. Complementary therapies for neuropathic and neuralgic pain. Clin J Pain 2008;24:731–733.
2. CaterinaMJ, LefflerA, MalmbergAB, MartinWJ, TraftonJ, Petersen-ZeitzKR, KoltzenburgM, BasbaumAI, JuliusD. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 2000;288:241–242.
3. HondaK, KitagawaJ, SessleBJ, KondoM, TsuboiY, YoneharaY, IwataK. Mechanisms involved in an increment of multimodal excitability of medullary and upper cervical dorsal horn neurons following cutaneous capsaicin treatment. Mol Pain 2008;4:59.
4. BackonjaM, WallaceMS, BlonskyER, CutlerBJ, MalanP Jr, RauckR, TobiasJ. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol 2008;7:1106–1112.
5. KnotkovaH, PappagalloM, SzallasiA. Capsaicin (TRPV1 agonist) therapy for pain relief: farewell or revival?Clin J Pain 2008;24:142–154.

References

1. RainsfordKD. Aspirin and Related Drugs. Illustrated. Boca Raton: CRC Press, 2004.
2. Mason et al. Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ 2004;328; 995.
3. Altman et al. Topical therapy for osteoarthritis: clinical and pharmacologic perspectives. Postgrad Med 2009;121(2):139–147.
4. ChykaPA, et al. Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 2007;45:95–131.
5. DavisJE. Are one or two dangerous? Methyl salicylate exposure in toddlers. J Emerg Med 2007;32(1):63–69.

References

1. KatzungBG. Basic & Clinical Pharmacology, 10th ed. New York: McGraw-Hill.
2. McPheeSJ, PapdakisMA. Current Medical Diagnosis & Treatment. New York: McGraw-Hill, 2009.
3. ClezardinP, GligorovJ, Delma, P. Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis. Joint Bone Spine 2000;67(1): 22–29.

References

1.Product insert, revised 10/08.
2. DeerT, KramesE, HassenbuschS, BurtonA, CarawayD, DupenS, EisenachJ, ErdekM, GrigsbyE, KimP, LevyR, McDowellG, MekhailN, PanchalSJ, PragerJ, RauckR, SaulinoM, SitzmanT, StaatsP, Stanton-HicksM, StearnsL, WillisKD, WittW, FollettK, HuntoonM, LiemL, RathmellJ, WallaceM, BuchserE, CousinsM, Ver Donck A. Polyanalgesic Consensus Conference 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 2007;10(4):300–328.

References

1. ThomasJ, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008;358:2332–2343.
2.Relistor subcutaneous injection package insert. Wyeth 2008. http://www.wyeth.com/hcp/relistor/prescribing-information.
3. ViscusiE, et al. Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability. Anesth Analg 2009;108:1811–1822.

References

1. Bream-RouwenhorstHR, CantrellMA. Alvimopan for postoperative ileus. Am J Health-System Pharm 2009;66:1267–1277.
2. DelaneyCP, YasothanU, KirkpatrickP. Alvimopan. Nature Rev 2008;7:727–728.
3. LudwigK, EnkerWE, DelaneyCP, WolffBG, DuW, FortJG, CherubiniM, CucinottaJ, TechnerL. Gastrointestinal tract recovery in patients undergoing bowel resection. Arch Surg 2008;143(11):1098–1105.
4. UdehE, GoldmanM. Alvimopan. Formulary 2005;40:176–183.